In today’s Pharmaceutical Executive Daily, we cover Lundbeck’s restructuring affecting more than 600 international employees, Novo Nordisk’s global plan to cut 9,000 jobs, and former President Trump’s push to rein in pharmaceutical direct-to-consumer advertising.
